Compounds we evaluate
These are prescription compounds — presented here for information only. There are no prices and nothing to buy. Each is available only after a licensed provider evaluates your intake and determines that treatment is clinically appropriate, and each is dispensed by a licensed compounding pharmacy.
A synthetic fragment of growth-hormone-releasing hormone (GHRH) that acts on the pituitary gland.
Studied in the clinical context of age-related decline in the body's own growth-hormone secretion.
A paired secretagogue (a GHRH analog with a ghrelin-receptor agonist) that signals the pituitary.
Researched as a combination approach to supporting the body's endogenous growth-hormone pathways.
A stabilized GHRH analog administered by subcutaneous injection.
Studied clinically in the context of visceral adipose (deep abdominal fat) reduction.
A melanocortin-receptor agonist that acts on pathways in the central nervous system.
Studied clinically in the context of sexual-health and libido concerns.
A glucagon-like peptide-1 (GLP-1) receptor agonist that influences appetite and glucose signaling.
Studied clinically in the context of metabolic health and weight management.
A dual GIP and GLP-1 receptor agonist affecting appetite and glucose regulation.
Studied clinically in the context of metabolic health and weight management.
Descriptions above are neutral and informational — they are not claims of safety or effectiveness, and they are not medical advice. A provider may determine any compound is not appropriate for you. Availability varies by state.
Request a Consultation